ANGO - Latest News
AngioDynamics, Inc. (ANGO), operates in Healthcare / Medical - Instruments & Supplies, trades on NASDAQ.
Market capitalization stands near $651.0M. Beta to the broader market is 0.32.
The article list below shows the most recent ANGO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ANGO Headlines
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
zacks.com - Aug 13, 2026
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock?
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
marketbeat.com - Aug 11, 2026
AngioDynamics NASDAQ: ANGO expects its MedTech business to become the majority of company revenue in fiscal 2027, as the company continues a multiyear
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
zacks.com - Aug 6, 2026
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncerta
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
zacks.com - Aug 6, 2026
AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
zacks.com - Aug 6, 2026
AngioDynamics' 33. 5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative earnings keep execution risks high.
How News Affects ANGO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ANGO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ANGO news questions
- What is the latest ANGO news headline?
- The most recent ANGO headline (Aug 13, 2026) is "AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ANGO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ANGO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ANGO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.